Jundishapur Journal of Microbiology

Published by: Kowsar

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

Ali Karimi 1 , Loghman Salimzadeh 1 , * and Nader Bagheri 2
Authors Information
1 Medicinal Plant Research Center, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
2 Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: April 01, 2014, 7 (4); e10196
  • Published Online: April 1, 2014
  • Article Type: Research Article
  • Received: February 4, 2013
  • Revised: May 5, 2013
  • Accepted: May 11, 2013
  • DOI: 10.5812/jjm.10196

To Cite: Karimi A, Salimzadeh L, Bagheri N. Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran, Jundishapur J Microbiol. 2014 ; 7(4):e10196. doi: 10.5812/jjm.10196.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003; 23(1): 39-46[DOI][PubMed]
  • 2. Maddrey WC. Hepatitis B--an important public health issue. Clin Lab. 2001; 47(1-2): 51-5[PubMed]
  • 3. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol. 2004; 72(3): 363-9[DOI][PubMed]
  • 4. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999; 12(2): 351-66[PubMed]
  • 5. Hannoun C, Horal P, Lindh M. Long-term mutation rates in the hepatitis B virus genome. J Gen Virol. 2000; 81: 75-83[PubMed]
  • 6. Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol. 2002; 83: 1267-80[PubMed]
  • 7. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988; 69 ( Pt 10): 2575-83[PubMed]
  • 8. Liu WC, Phiet PH, Chiang TY, Sun KT, Hung KH, Young KC, et al. Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics. Virus Res. 2007; 129(2): 212-23[DOI][PubMed]
  • 9. Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J. 2008; 5: 156[DOI][PubMed]
  • 10. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001; 34(3): 590-4[DOI][PubMed]
  • 11. Chin R, Locarnini S. Treatment of chronic hepatitis B: current challenges and future directions. Rev Med Virol. 2003; 13(4): 255-72[DOI][PubMed]
  • 12. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003; 362(9401): 2089-94[DOI][PubMed]
  • 13. Patel PC, Cockcroft DW. Occupational asthma caused by exposure to cooking lobster in the work environment: a case report. Ann Allergy. 1992; 68(4): 360-1[PubMed]
  • 14. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method. J Infect Dis. 1997; 175(6): 1285-93[PubMed]
  • 15. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol. 2005; 76(3): 318-26[DOI][PubMed]
  • 16. Mojiri A, Behzad-Behbahani A, Saberifirozi M, Ardabili M, Beheshti M, Rahsaz M, et al. Hepatitis B virus genotypes in southwest Iran: molecular, serological and clinical outcomes. World J Gastroenterol. 2008; 14(10): 1510-3[PubMed]
  • 17. Bahramali G, Sadeghizadeh M, Amini-Bavil-Olyaee S, Alavian SM, Behzad-Behbahani A, Adeli A, et al. Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. World J Gastroenterol. 2008; 14(35): 5448-53[PubMed]
  • 18. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 19. Severini A, Liu XY, Wilson JS, Tyrrell DL. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother. 1995; 39(7): 1430-5[PubMed]
  • 20. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med. 1999; 341(17): 1256-63[DOI][PubMed]
  • 21. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med. 1998; 339(2): 61-8[DOI][PubMed]
  • 22. Wang JH, Lu SN, Lee CM, Lee JF, Chou YP. Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis. Scand J Gastroenterol. 2002; 37(3): 366-9[PubMed]
  • 23. Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance. J Hepatol. 2002; 36(2): 303-4[PubMed]
  • 24. Papatheodoridis GV, Dimou E, Papadimitropoulos V. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. Am J Gastroenterol. 2002; 97(7): 1618-28[DOI][PubMed]
  • 25. Bottecchia M, Souto FJ, O KM, Amendola M, Brandao CE, Niel C, et al. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil. BMC Microbiol. 2008; 8: 11[DOI][PubMed]
  • 26. Zollner B, Petersen J, Puchhammer-Stockl E, Kletzmayr J, Sterneck M, Fischer L, et al. Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology. 2004; 39(1): 42-50[DOI][PubMed]
  • 27. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology. 1998; 27(6): 1670-7[DOI][PubMed]
  • 28. Palumbo E. Hepatitis B genotypes and response to antiviral therapy: a review. Am J Ther. 2007; 14(3): 306-9[DOI][PubMed]
  • 29. Karimi A, Hoseini SM. Seroprevalence of hepatitis B and C virus and HIV markers among blood donors from Shahre-Kord, Iran (2004-2006). Kuwait Med J. 2008; 40(4): 279-81
  • 30. Mokhtarian K, Karimi A. Evaluation of Vaccine Induced Immunity to Hepatitis B Virus among Health Care Workers in a University Hospital in Iran. Kuwait Med J. 2010; 42: 202-4
  • 31. Karimi A, Imani R. [Prevalence of Hbsag, Hcv And Hiv Antibodies Among Intravenous Drug Users In Shahre-Kord, Iran]. J Isfahan Med School. 2007; 8: 10-4
  • 32. Zhang XH, Zhang YX, Sun LR, Wen Q, Zhou LQ, Fan GX, et al. [Study of gene chips in the detection of YMDD mutations in the region of HBV polymeras]. Zhonghua Yi Xue Za Zhi. 2003; 83(6): 459-62[PubMed]
  • 33. Akarsu M, Sengonul A, Tankurt E, Sayiner AA, Topalak O, Akpinar H, et al. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay. J Gastroenterol Hepatol. 2006; 21(12): 1783-8[DOI][PubMed]
  • 34. Yan MH, Zhang C, Ling Q, Zhou RF. [Detection of YMDD motif mutations in lamivudine-untreated patients with chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 2003; 11(7): 430-1[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments